ReviewCancers2025

Denosumab vs. Zoledronic Acid for Metastatic Bone Disease: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Benjamin G Wajda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.